Analyzing the Safety and Efficacy of Lenvatinib Plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma Physician's Weekly, 09 Jan 2023 The following is a summary of “A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and…